FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2075649492> ?p ?o ?g. }

• W2075649492 endingPage "S118" @default.
• W2075649492 startingPage "S111" @default.
• W2075649492 abstract "Seasonal influenza continues to have a huge annual impact in the United States, accounting for tens of millions of illnesses, hundreds of thousands of excess hospitalizations, and tens of thousands of excess deaths. Vaccination remains the mainstay for the prevention of influenza. In the United States, 2 types of influenza vaccine are currently licensed: trivalent inactivated influenza vaccine and live attenuated influenza vaccine. Both are safe and effective in the populations for which they are approved for use. Children, adults <65 years of age, and the elderly all receive substantial health benefits from vaccination. In addition, vaccination appears to be cost-effective, if not cost saving, across the age spectrum. Despite long-standing recommendations for the routine vaccination of persons in high-priority groups, US vaccination rates remain too low across all age groups. Important issues to be addressed include improving vaccine delivery to current and expanded target groups, ensuring timely availability of adequate vaccine supply, and development of even more effective vaccines. Development of a vaccine against potentially pandemic strains is an essential part of the strategy to control and prevent a pandemic outbreak. The use of existing technologies for influenza vaccine production would be the most straightforward approach, because these technologies are commercially available and licensing would be relatively simple. Approaches currently being tested include subvirion inactivated vaccines and cold-adapted, live attenuated vaccines. Preliminary results have suggested that, for some pandemic antigens, particularly H5, subvirion inactivated vaccines are poorly immunogenic, for reasons that are not clear. Data from evaluation of live pandemic vaccines are pending. Second-generation approaches designed to provide improved immune responses at lower doses have focused on adjuvants such as alum and MF59, which are currently licensed for influenza or other vaccines. Additional experimental approaches are required to achieve the ultimate goal for seasonal and pandemic influenza prevention--namely, the ability to generate broadly cross-reactive and durable protection in humans." @default.
• W2075649492 created "2016-06-24" @default.
• W2075649492 creator A5083732628 @default.
• W2075649492 creator A5089157167 @default.
• W2075649492 date "2006-11-01" @default.
• W2075649492 modified "2023-09-25" @default.
• W2075649492 title "Vaccines for Seasonal and Pandemic Influenza" @default.
• W2075649492 cites W1967661843 @default.
• W2075649492 cites W1969287126 @default.
• W2075649492 cites W1981138838 @default.
• W2075649492 cites W1988729025 @default.
• W2075649492 cites W1990817586 @default.
• W2075649492 cites W2016131540 @default.
• W2075649492 cites W2016143593 @default.
• W2075649492 cites W2025333144 @default.
• W2075649492 cites W2027741520 @default.
• W2075649492 cites W2033564753 @default.
• W2075649492 cites W2034382342 @default.
• W2075649492 cites W2036596307 @default.
• W2075649492 cites W2040210640 @default.
• W2075649492 cites W2047562582 @default.
• W2075649492 cites W2047838565 @default.
• W2075649492 cites W2049999229 @default.
• W2075649492 cites W2058144955 @default.
• W2075649492 cites W2059316621 @default.
• W2075649492 cites W2063554346 @default.
• W2075649492 cites W2069442471 @default.
• W2075649492 cites W2087508560 @default.
• W2075649492 cites W2093537573 @default.
• W2075649492 cites W2095044543 @default.
• W2075649492 cites W2098832466 @default.
• W2075649492 cites W2114555019 @default.
• W2075649492 cites W2114711026 @default.
• W2075649492 cites W2115037143 @default.
• W2075649492 cites W2115712035 @default.
• W2075649492 cites W2121448075 @default.
• W2075649492 cites W2131170401 @default.
• W2075649492 cites W2134691437 @default.
• W2075649492 cites W2139841187 @default.
• W2075649492 cites W2144748417 @default.
• W2075649492 cites W2159850238 @default.
• W2075649492 cites W2164793043 @default.
• W2075649492 cites W2312219549 @default.
• W2075649492 cites W3147980320 @default.
• W2075649492 cites W4234687867 @default.
• W2075649492 doi "https://doi.org/10.1086/507544" @default.
• W2075649492 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17163383" @default.
• W2075649492 hasPublicationYear "2006" @default.
• W2075649492 type Work @default.
• W2075649492 sameAs 2075649492 @default.
• W2075649492 citedByCount "204" @default.
• W2075649492 countsByYear W20756494922012 @default.
• W2075649492 countsByYear W20756494922013 @default.
• W2075649492 countsByYear W20756494922014 @default.
• W2075649492 countsByYear W20756494922015 @default.
• W2075649492 countsByYear W20756494922016 @default.
• W2075649492 countsByYear W20756494922017 @default.
• W2075649492 countsByYear W20756494922018 @default.
• W2075649492 countsByYear W20756494922019 @default.
• W2075649492 countsByYear W20756494922020 @default.
• W2075649492 countsByYear W20756494922021 @default.
• W2075649492 countsByYear W20756494922022 @default.
• W2075649492 countsByYear W20756494922023 @default.
• W2075649492 crossrefType "journal-article" @default.
• W2075649492 hasAuthorship W2075649492A5083732628 @default.
• W2075649492 hasAuthorship W2075649492A5089157167 @default.
• W2075649492 hasConcept C104317684 @default.
• W2075649492 hasConcept C116675565 @default.
• W2075649492 hasConcept C133239900 @default.
• W2075649492 hasConcept C142724271 @default.
• W2075649492 hasConcept C159047783 @default.
• W2075649492 hasConcept C192805744 @default.
• W2075649492 hasConcept C203014093 @default.
• W2075649492 hasConcept C22070199 @default.
• W2075649492 hasConcept C2776872762 @default.
• W2075649492 hasConcept C2779134260 @default.
• W2075649492 hasConcept C2780689484 @default.
• W2075649492 hasConcept C3008058167 @default.
• W2075649492 hasConcept C524204448 @default.
• W2075649492 hasConcept C54602769 @default.
• W2075649492 hasConcept C55493867 @default.
• W2075649492 hasConcept C60987743 @default.
• W2075649492 hasConcept C71924100 @default.
• W2075649492 hasConcept C86803240 @default.
• W2075649492 hasConcept C89623803 @default.
• W2075649492 hasConcept C99454951 @default.
• W2075649492 hasConceptScore W2075649492C104317684 @default.
• W2075649492 hasConceptScore W2075649492C116675565 @default.
• W2075649492 hasConceptScore W2075649492C133239900 @default.
• W2075649492 hasConceptScore W2075649492C142724271 @default.
• W2075649492 hasConceptScore W2075649492C159047783 @default.
• W2075649492 hasConceptScore W2075649492C192805744 @default.
• W2075649492 hasConceptScore W2075649492C203014093 @default.
• W2075649492 hasConceptScore W2075649492C22070199 @default.
• W2075649492 hasConceptScore W2075649492C2776872762 @default.
• W2075649492 hasConceptScore W2075649492C2779134260 @default.
• W2075649492 hasConceptScore W2075649492C2780689484 @default.
• W2075649492 hasConceptScore W2075649492C3008058167 @default.

• next